Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Portfolio Pulse from Benzinga Insights
Revvity (NYSE:RVTY) has been evaluated by 7 analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target is now $112.29, down from $131.33, with a high estimate of $135.00 and a low of $95.00. Analysts from firms like Evercore ISI Group, Wells Fargo, Raymond James, Goldman Sachs, Keybanc, and JP Morgan have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Revvity operates in diagnostics and discovery/analytical solutions, serving various markets. Financially, the company has a lower market cap compared to industry averages, a negative revenue trend, a high net margin, but lower ROE and ROA than industry benchmarks, and a conservative debt-to-equity ratio.
January 04, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revvity's average 12-month price target has been lowered to $112.29, indicating a bearish sentiment among analysts. The company's financial performance shows a negative revenue trend but a strong net margin, suggesting mixed financial health.
The reduction in the average price target by analysts suggests a bearish outlook, which could lead to a short-term negative impact on the stock price. However, the company's strong net margin may mitigate some concerns. The negative revenue trend and lower ROE and ROA compared to industry averages are concerning and could further pressure the stock.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100